Loading...
Low-dose aspirin can lower risk for colorectal cancer and increase survival in patients following treatment for colon cancer. To explore the impact of daily aspirin on survival in women who received standard treatment for endometrial cancer, researchers performed a retrospective analysis including 158 women with endometrial cancer who were taking daily oral low-dose aspirin (81–100 mg) and 1529 women who were not taking aspirin.
At an overall median follow-up of 31.5 months, 5-year disease-free-survival rates were 90% and 81% among women who did take and did not use low-dose aspirin, respectively (P=0.015). This beneficial effect was most prominent in young women, obese women, and those with favorable tumor histology. Women in the aspirin gr…